Volume 8, Issue 1 (January & February 2017 -- 2017)                   BCN 2017, 8(1): 5-12 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Khalaji N, Sarkissian J, Chavushyan V, Sarkisian V. Protective Effects of Proline–Rich Peptide in a Rat Model of Alzheimer Disease: An Electrophysiological Study. BCN 2017; 8 (1) :5-12
URL: http://bcn.iums.ac.ir/article-1-668-en.html
1- Department of Physiology, School of Medicine, Uremia University of Medical Sciences, Uremia, Iran.
2- Orbeli Institute of Physiology, National Academy of Sciences of the Republic of Armenia, Yerevan, Republic of Armenia.
Abstract:  

Introduction: Alzheimer disease (AD) is the most common form of dementia in the elderly that slowly destroys memory and cognitive functions. The disease has no cure and leads to significant structural and functional brain abnormalities. To facilitate the treatment of this disease, we aimed to investigate proline-rich peptide (PRP-1) action of hypothalamus on hippocampal (HP) neurons and dynamics of their recovery, after intracerebroventricular (ICV) injection of amyloid-β (Aβ).
Methods: Experiments were carried out on 24 adult, male Albino rats (average weight: 230±30 g). The animals were randomly divided into 3 groups (control, Aβ, and Aβ plus PRP-1). Electrophysiological patterns of hippocampal neurons in response to stimulation of entorhinal cortex (EC) with high frequency stimulation (50 Hz) were studied.
Results: It was found that Aβ (25-35) suppresses the electrical activity of hippocampal neurons. The PRP-1 would return this activity to normal levels.
Conclusion: In general, PRP-1 has protective effect against AD-related alterations induced byamyloid peptides. This protective effect is probably due to stimulation of the immune and glia system.

Type of Study: Original | Subject: Clinical Neuroscience
Received: 2016/05/13 | Accepted: 2016/09/10 | Published: 2017/01/1

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Basic and Clinical Neuroscience

Designed & Developed by : Yektaweb